{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:51:04Z","timestamp":1777895464608,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clnesp.2024.05.021","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T19:42:28Z","timestamp":1717011748000},"page":"278-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical significance and normal reference value of serum creatinine to cystatin C ratio in children"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9657-1646","authenticated-orcid":false,"given":"Hidehito","family":"Ota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Kunikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomosato","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Ebishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3018-5398","authenticated-orcid":false,"given":"Hikoro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2024.05.021_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2024.05.021_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/lt.25985","article-title":"Sarcopenia in children with end-stage liver disease on the transplant waiting list","volume":"27","author":"Woolfson","year":"2021","journal-title":"Liver Transplant"},{"key":"10.1016\/j.clnesp.2024.05.021_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28862","article-title":"Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma","volume":"68","author":"Ritz","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clnesp.2024.05.021_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41430-021-01016-y","article-title":"Prognostic impact of sarcopenia in children with cancer: a focus on the psoas muscle area (PMA) imaging in the clinical practice","volume":"76","author":"Triarico","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib5","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.clnu.2019.04.012","article-title":"Low muscle mass and strength in pediatrics patients: Why should we care?","volume":"38","author":"Orsso","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00247-019-04562-7","article-title":"Quantification of skeletal muscle mass: sarcopenia as a marker of overall health in children and adults","volume":"50","author":"Gilligan","year":"2020","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.clnesp.2024.05.021_bib7","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","article-title":"Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index","volume":"45","author":"Kashani","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clnesp.2024.05.021_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ncn3.11","article-title":"Creatinine\/cystatin C ratio as a surrogate marker of residual muscle mass in amyotrophic lateral sclerosis","volume":"1","author":"Tetsuka","year":"2013","journal-title":"Neurology and Clinical Neuroscience"},{"key":"10.1016\/j.clnesp.2024.05.021_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11255-018-2015-6","article-title":"The creatinine\/cystatin C ratio provides effective evaluation of muscle mass in kidney transplant recipients","volume":"51","author":"Yanishi","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.clnesp.2024.05.021_bib10","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.clnu.2019.07.027","article-title":"Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study","volume":"39","author":"Tabara","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib11","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.clnu.2019.10.027","article-title":"Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease","volume":"39","author":"Lin","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1507\/endocrj.EJ19-0542","article-title":"Creatinine\/(cystatin C\u00a0\u00d7 body weight) ratio is associated with skeletal muscle mass index","volume":"67","author":"Nishida","year":"2020","journal-title":"Endocr J"},{"key":"10.1016\/j.clnesp.2024.05.021_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.110895","article-title":"Creatinine-to-cystatin C ratio and bioelectrical impedance analysis for the assessement of low lean body mass in cancer patients: comparison to L3-computed tomography scan","volume":"81","author":"Ulmann","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.clnesp.2024.05.021_bib14","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.clnu.2020.08.010","article-title":"Serum creatinine\/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease","volume":"40","author":"Hirai","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clnesp.2022.07.010","article-title":"Relationship between the creatinine\/cystatin C ratio and muscle mass measured by CT-scan in cancer patients","volume":"51","author":"Tlemsani","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnesp.2024.05.021_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3164\/jcbn.21-61","article-title":"Association of serum creatinine-to-cystatin C ratio with skeletal muscle mass and strength in nonalcoholic fatty liver disease in the Iwaki Health Promotion Project","volume":"70","author":"Mikami","year":"2022","journal-title":"J\u00a0Clin Biochem Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib17","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41598-020-58304-z","article-title":"Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients","volume":"10","author":"Tang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2024.05.021_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.897774","article-title":"Diagnostic and prognostic value of the Creatinine\/Cystatin C ratio for low muscle mass evaluation among US adults","volume":"9","author":"Shi","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1462","article-title":"Predictive value of serum creatinine\/cystatin C in neurocritically ill patients","volume":"9","author":"Wang","year":"2019","journal-title":"Brain Behav"},{"key":"10.1016\/j.clnesp.2024.05.021_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12603-020-1495-0","article-title":"Predictive value of serum creatinine\/cystatin C in acute ischemic stroke patients under nutritional intervention","volume":"25","author":"Liu","year":"2021","journal-title":"J\u00a0Nutr Health Aging"},{"key":"10.1016\/j.clnesp.2024.05.021_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13098-022-00958-y","article-title":"Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study","volume":"14","author":"Wei","year":"2022","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.clnesp.2024.05.021_bib22","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jcsm.13006","article-title":"Creatinine-cystatin C ratio and mortality in cancer patients: a retrospective cohort study","volume":"13","author":"Jung","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2024.05.021_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.996674","article-title":"Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease","volume":"9","author":"Hyun","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1186\/s12877-022-03626-y","article-title":"Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00408-022-00568-5","article-title":"Serum creatinine\/cystatin C ratio as a predictor of in-hospital mortality in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease","volume":"200","author":"Chen","year":"2022","journal-title":"Lung"},{"key":"10.1016\/j.clnesp.2024.05.021_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000494296","article-title":"The ratio serum creatinine\/serum cystatin C (a surrogate marker of muscle mass) as a predictor of hospitalization in chronic obstructive pulmonary disease outpatients","volume":"97","author":"Amado","year":"2019","journal-title":"Respiration"},{"key":"10.1016\/j.clnesp.2024.05.021_bib27","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.21037\/apm-20-2366","article-title":"Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass for predicting postoperative complications in patients undergoing gastric cancer surgery","volume":"10","author":"Gao","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.clnesp.2024.05.021_bib28","article-title":"Association between muscle mass evaluated by computed tomography and the serum creatinine-cystatin C ratio in children with cancer: a cross-sectional study","volume":"99\u2013100","author":"Kishimoto","year":"2022","journal-title":"Nutrition"},{"key":"10.1016\/j.clnesp.2024.05.021_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.braindev.2021.10.006","article-title":"Creatinine-to-cystatin C ratio estimates muscle mass correlating the markers of the patients with severe motor and intellectual disabilities","volume":"44","author":"Nakahara","year":"2022","journal-title":"Brain Dev"},{"key":"10.1016\/j.clnesp.2024.05.021_bib30","first-page":"3151","article-title":"Age- and sex-specific reference intervals for the serum cystatin C\/creatinine ratio in healthy children (0-18 years old)","volume":"47","author":"Liu","year":"2019","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.clnesp.2024.05.021_bib31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1017\/S000711451800082X","article-title":"Body composition during early infancy and developmental progression from 1 to 5 years of age: the Infant Anthropometry and Body Composition (iABC) cohort study among Ethiopian children","volume":"119","author":"Abera","year":"2018","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnesp.2024.05.021_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000487915","article-title":"Body composition changes from infancy to 4 Years and associations with early childhood cognition in preterm and full-term children","volume":"114","author":"Scheurer","year":"2018","journal-title":"Neonatology"},{"key":"10.1016\/j.clnesp.2024.05.021_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113637","article-title":"Grip strength across the life course: normative data from twelve British studies","volume":"9","author":"Dodds","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2024.05.021_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00223-013-9830-7","article-title":"Total and appendicular lean mass reference ranges for Australian men and women: the Geelong osteoporosis study","volume":"94","author":"Gould","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clnesp.2024.05.021_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.2047-6310.2013.00168.x","article-title":"Skeletal muscle mass reference curves for children and adolescents","volume":"9","author":"McCarthy","year":"2014","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.clnesp.2024.05.021_bib36","article-title":"Reference values of skeletal muscle mass for Korean children and adolescents using data from the Korean national health and nutrition examination survey 2009-2011","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2024.05.021_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fendo.2019.00583","article-title":"Muscle mass in children and adolescents: proposed equations and reference values for assessment","volume":"10","author":"Cossio Bola\u00f1os","year":"2019","journal-title":"Front Endocrinol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724001402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724001402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T22:58:46Z","timestamp":1718751526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724001402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":37,"alternative-id":["S2405457724001402"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.05.021","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance and normal reference value of serum creatinine to cystatin C ratio in children","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}